← FDA Drug Approvals (Drugs@FDA)

TERLIVAZ

NDA · New Drug Application · Sponsor: MALLINCKRODT IRELAND · Approved 2022-09-14

Drug application

FDA Application #

NDA022231

Application type

New Drug Application

Brand name

TERLIVAZ

Generic name

TERLIPRESSIN

Active ingredients

TERLIPRESSIN ACETATE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MALLINCKRODT IRELAND

Manufacturer

Mallinckrodt Hospital Products Inc.

First approval

2022-09-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown